Insider Trading History of Huang Jane

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Huang Jane since 2017. This trader's CIK number is 1683913. At the time of last reporting, Huang Jane was the President, CMO of Prelude Therapeutics Inc. (stock ticker symbol PRLD). Also see all insider trading activities at Prelude Therapeutics Inc.

Note that in the past Huang Jane also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Prelude Therapeutics Inc (PRLD) by Huang Jane

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 PRLD 0 $0 0 $0 28,125 $0
2024 PRLD 0 $0 0 $0 37,500 $0
2023 PRLD 0 $0 13,280 $81,273 56,250 $0

Yearly summary of insider trading at Beone Medicines Ltd. (BGNE) by Huang Jane

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 BGNE 0 $0 53,609 $18,656,045 37,500 $4,620,057
2020 BGNE 0 $0 31,194 $6,659,046 27,000 $1,778,054
2019 BGNE 0 $0 71,170 $11,692,550 67,725 $2,156,437
2018 BGNE 0 $0 5,911 $926,995 3,000 $88,470
2017 BGNE 0 $0 5,200 $472,156 2,500 $73,775


Insider trading activities at 2 companies by Huang Jane:

1. Prelude Therapeutics Inc (PRLD)

2. Beone Medicines Ltd. (BGNE)

Table 1. Insider trading of Prelude Therapeutics Inc (PRLD) by Huang Jane

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-04 PRLD Option Ex 9,375 .00 0
2025-04-04 PRLD Option Ex 9,375 .00 0
2025-01-04 PRLD Option Ex 9,375 .00 0
2024-10-04 PRLD Option Ex 9,375 .00 0
2024-07-04 PRLD Option Ex 9,375 .00 0
2024-04-04 PRLD Option Ex 9,375 .00 0
2024-01-04 PRLD Option Ex 9,375 .00 0
2023-10-04 PRLD Option Ex 9,375 .00 0
2023-07-04 PRLD Option Ex 9,375 .00 0
2023-04-04 PRLD Option Ex 37,500 .00 0
2023-04-06 PRLD Sale 13,280 6.12 81,273

Table 2. Insider trading of Beone Medicines Ltd. (BGNE) by Huang Jane

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-14 BGNE Option Ex 1,500 119.96 179,940
2021-12-14 BGNE Sale 1,500 279.11 418,662
2021-12-01 BGNE Sale 1,049 359.89 377,520
2021-11-17 BGNE Option Ex 1,500 119.96 179,940
2021-11-17 BGNE Sale 1,500 381.37 572,052
2021-10-19 BGNE Option Ex 1,500 119.96 179,940
2021-10-19 BGNE Sale 1,500 372.39 558,586
2021-09-20 BGNE Option Ex 6,000 119.96 719,760
2021-09-20 BGNE Sale 6,000 399.96 2,399,760
2021-09-13 BGNE Sale 12,901 359.46 4,637,432
2021-09-01 BGNE Sale 542 310.53 168,307
2021-09-02 BGNE Sale 545 327.18 178,313
2021-07-15 BGNE Option Ex 21,000 151.60 3,183,537
2021-07-15 BGNE Sale 21,000 333.21 6,997,452
2021-06-18 BGNE Sale 469 325.66 152,733
2021-06-07 BGNE Sale 603 351.55 211,985
2021-04-29 BGNE Sale 1,500 354.48 531,712
2021-04-29 BGNE Option Ex 1,500 29.49 44,235
2021-03-29 BGNE Option Ex 1,500 29.49 44,235
2021-03-29 BGNE Sale 1,500 324.25 486,370
2021-02-26 BGNE Option Ex 1,500 29.49 44,235
2021-02-26 BGNE Sale 1,500 319.27 478,906
2021-01-29 BGNE Sale 1,500 324.17 486,255
2021-01-29 BGNE Option Ex 1,500 29.49 44,235
2020-12-29 BGNE Sale 1,500 248.87 373,303
2020-12-29 BGNE Option Ex 1,500 29.49 44,235
2020-11-30 BGNE Option Ex 1,500 29.49 44,235
2020-11-30 BGNE Sale 1,500 268.94 403,408
2020-10-29 BGNE Option Ex 1,500 29.49 44,235
2020-10-29 BGNE Sale 1,500 300.70 451,045
2020-09-29 BGNE Sale 1,500 280.16 420,242
2020-09-29 BGNE Option Ex 1,500 29.49 44,235
2020-09-03 BGNE Sale 3,128 233.64 730,829
2020-08-28 BGNE Sale 3,000 242.37 727,104
2020-08-28 BGNE Option Ex 3,000 29.49 88,470
2020-07-29 BGNE Option Ex 3,000 94.94 284,835
2020-07-29 BGNE Sale 3,000 210.93 632,796
2020-07-07 BGNE Sale 3,921 200.00 784,200
2020-07-07 BGNE Option Ex 3,921 160.40 628,928
2020-06-26 BGNE Option Ex 2,079 160.40 333,471
2020-06-26 BGNE Sale 2,079 200.29 416,396
2020-06-29 BGNE Option Ex 1,500 29.49 44,235
2020-06-29 BGNE Sale 1,935 191.16 369,896
2020-06-08 BGNE Sale 631 170.84 107,800
2020-05-29 BGNE Sale 1,500 163.91 245,863
2020-05-29 BGNE Option Ex 1,500 29.49 44,235
2020-04-29 BGNE Sale 1,500 162.30 243,450
2020-04-29 BGNE Option Ex 1,500 29.49 44,235
2020-04-16 BGNE Sale 1,500 160.00 240,000
2020-04-16 BGNE Option Ex 1,500 29.49 44,235
2020-02-18 BGNE Sale 1,500 170.57 255,862
2020-02-18 BGNE Option Ex 1,500 29.49 44,235
2020-01-21 BGNE Option Ex 1,500 29.49 44,235
2020-01-21 BGNE Sale 1,500 171.24 256,852
2019-12-16 BGNE Option Ex 1,500 29.49 44,235
2019-12-16 BGNE Sale 1,500 167.56 251,334
2019-11-18 BGNE Sale 1,500 195.13 292,689
2019-11-18 BGNE Option Ex 1,500 29.49 44,235
2019-11-04 BGNE Option Ex 32,900 29.49 970,221
2019-11-04 BGNE Sale 32,900 190.96 6,282,715
2019-09-04 BGNE Sale 82 129.40 10,610
2019-09-03 BGNE Sale 2,862 144.68 414,062
2019-08-12 BGNE Sale 2,500 134.90 337,237
2019-08-12 BGNE Option Ex 2,500 45.31 113,275
2019-07-29 BGNE Option Ex 10,130 37.40 378,862
2019-07-29 BGNE Sale 10,130 133.97 1,357,075
2019-06-27 BGNE Sale 430 125.42 53,929
2019-05-21 BGNE Sale 2,200 130.06 286,132
2019-05-20 BGNE Sale 300 130.12 39,036
2019-05-21 BGNE Option Ex 2,200 45.31 99,682
2019-05-20 BGNE Option Ex 300 45.31 13,593
2019-04-08 BGNE Sale 14,130 143.26 2,024,306
2019-04-08 BGNE Option Ex 14,130 29.49 416,693
2019-03-07 BGNE Sale 71 140.50 9,975
2019-03-11 BGNE Sale 2,565 130.00 333,450
2019-03-11 BGNE Option Ex 2,565 29.49 75,641
2018-11-26 BGNE Option Ex 3,000 29.49 88,470
2018-11-26 BGNE Sale 3,000 139.58 418,749
2018-09-04 BGNE Sale 2,911 174.59 508,246
2017-12-21 BGNE Sale 1,000 98.00 98,000
2017-12-21 BGNE Option Ex 1,000 29.51 29,510
2017-12-13 BGNE Option Ex 1,500 29.51 44,265
2017-12-13 BGNE Sale 1,500 94.37 141,556
2017-12-04 BGNE Sale 1,100 86.00 94,600
2017-11-16 BGNE Sale 600 85.00 51,000
2017-11-20 BGNE Sale 1,000 87.00 87,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Huang Jane (President, CMO of Prelude Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.